Active ingredientDotinuradCat. No. P-D177-001CAS 1285572-51-1Family · Pharmaceutical analytical standards
Dotinurad
A uricosuric that inhibits the URAT1 transporter in the kidney, so less uric acid is reabsorbed and more is excreted in urine: approved in Japan in 2020 and in China in 2024 for gout and hyperuricaemia. This family brings together the active ingredient and other impurities.
Did you know?Chemically it is related to benzbromarone, an older uricosuric, but it was designed to act selectively on URAT1: hence it is called a SURI, a selective urate reabsorption inhibitor.
Go to the active ingredient →Active ingredientDotinuradCat. No. P-D177-001CAS 1285572-51-1
ImpurityBis(2-aminophenyl) disulfideCat. No. P-D177-002CAS 1141-88-4
ImpurityDotinurad Impurity 1Cat. No. P-D177-003
ImpurityDotinurad Impurity 2Cat. No. P-D177-004
ImpurityDotinurad Impurity 3Cat. No. P-D177-005
ImpurityDotinurad Impurity 4Cat. No. P-D177-006
ImpurityDotinurad Impurity 5Cat. No. P-D177-007
ImpurityDotinurad Impurity 6Cat. No. P-D177-008
ImpurityDotinurad Impurity 7Cat. No. P-D177-009
ImpurityDotinurad Impurity 8Cat. No. P-D177-010
ImpurityDotinurad Impurity 9Cat. No. P-D177-011No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.